POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF

• 收藏
• 分享

专利权人:

Alnylam Pharmaceuticals; Inc.

发明人:

Gregory Hinkle

申请号：

US15450326

公开号：

US20170183659A1

申请日:

2017.03.06

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The invention relates to polynucleotide agents targeting the complement component C5 gene, and methods of using such polynucleotide agents to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/